Home » Danish Regulator Clarifies Trial Safety Information Requirements
Danish Regulator Clarifies Trial Safety Information Requirements
November 11, 2013
Sponsors and sites should base potential adverse reaction profiles of drugs in clinical trials on previously observed events, rather than anticipated pharmacological properties, the Danish Health and Medicines Authority says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor